Ginkgo Bioworks Holdings, Inc. (DNA) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-15

Ginkgo Bioworks Holdings, Inc. (DNA) has filed 6 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-15. 2 Form 8-K material event filings were reported by DNA in the last 90 days. 3 Form 144 notices of proposed sale were filed for DNA stock. InsiderAlpha tracks every DNA SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Ginkgo Bioworks Holdings, Inc. (DNA)

SIC classification	Biological Products, (No Diagnostic Substances) (SIC 2836)
SEC CIK	0001830214

90-Day SEC Filing Activity

Form 4 filings (90d)	6
Form 8-K filings (90d)	2
Form 144 notices (90d)	3
Latest Form 4 filing	2026-06-15

Recent DNA Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-05-22	Coen Steven P.	See remarks	S — Open-market sale	307	$8.33	$3K	SEC
2026-05-21	Coen Steven P.	See remarks	M — Option exercise	587	—	—	SEC
2026-05-21	Coen Steven P.	See remarks	M — Option exercise	156	—	—	SEC
2026-04-17	Coen Steven P.	See remarks	S — Open-market sale	324	$7.95	$3K	SEC
2026-04-16	Coen Steven P.	See remarks	M — Option exercise	156	—	—	SEC
2026-04-16	Coen Steven P.	See remarks	M — Option exercise	587	—	—	SEC
2026-04-13	Coen Steven P.	See remarks	S — Open-market sale	33.2K	$6.41	$213K	SEC
2026-04-10	Coen Steven P.	See remarks	M — Option exercise	28.4K	—	—	SEC
2026-04-10	Canton Barry	10% Owner	S — Open-market sale	124.7K	$6.43	$802K	SEC
2026-04-10	Shetty Reshma P.	See remarks	S — Open-market sale	124.7K	$6.43	$802K	SEC
2026-04-10	Coen Steven P.	See remarks	M — Option exercise	45.6K	—	—	SEC
2026-04-09	Canton Barry	10% Owner	M — Option exercise	251.8K	—	—	SEC
2026-04-09	Kelly Jason R	See remarks	S — Open-market sale	109.8K	$6.40	$702K	SEC
2026-04-09	Canton Barry	10% Owner	S — Open-market sale	13.1K	$6.40	$84K	SEC
2026-04-09	Shetty Reshma P.	See remarks	M — Option exercise	251.8K	—	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Ginkgo Bioworks Holdings, Inc. (DNA). Updated in real time as new filings are submitted to the SEC.

Most-Active DNA Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Coen Steven P.	10	$5K
SLOAN HARRY	1	—
HENRY CHRISTIAN O	1	—
Kosuri Sri	1	—
Fubini Ross	1	—

Recent DNA Form 8-K Material Events

2026-06-12 — Item 5.07 [SEC]
2026-05-07 — Item 2.02, 9.01 [SEC]
2026-04-07 — Item 2.01, 9.01 · Acquisition · neutral [SEC]
Ginkgo Bioworks completed the sale of its Biosecurity segment (Ginkgo Biosecurity, LLC) to Tower Biosecurity, Inc. (also known as Perimeter Systems, Inc.) on April 3, 2026, pursuant to a Stock Purchase Agreement dated February 26, 2026. In exchange, Ginkgo received approximately
2026-02-27 — Item 1.01, 9.01 · Acquisition · neutral [SEC]
Ginkgo Bioworks is divesting its Biosecurity segment by contributing all equity interests of Ginkgo Biosecurity LLC to Tower Biosecurity, Inc. in exchange for approximately 20% ownership of Tower on a fully diluted basis. The transaction is expected to close in H1 2026 subject to
2026-02-26 — Item 2.02 · Earnings · neutral [SEC]
Ginkgo Bioworks announced Q4 2025 and full-year 2025 financial results via press release on February 26, 2026. The 8-K provides no detail on whether results beat, missed, or met expectations, nor does it contain guidance changes, surprise language, or material operational updates

Recent DNA Form 144 Notices of Proposed Sale

2026-06-10 — — [SEC]
2026-05-22 — — [SEC]
2026-05-13 — — [SEC]

Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.

Recent Insider Filings

2026-06-15 — HENRY CHRISTIAN O (Director)
2026-06-15 — Fubini Ross (Director)
2026-06-15 — Kosuri Sri (Director)
2026-06-15 — SLOAN HARRY (Director)
2026-05-26 — Coen Steven P. (See remarks)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in DNA insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

DNA Insider Trading — FAQ

What is the latest insider trade for DNA?: Ginkgo Bioworks Holdings, Inc. (DNA) had 6 insider filings in the last 90 days, with the most recent on 2026-06-15. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying DNA stock?: 0 insider purchases of DNA were filed in the last 90 days.
How many insiders are selling DNA stock?: 0 insider sales of DNA were filed in the last 90 days.
Where can I see DNA SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every DNA SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Related Companies — Recent Insider Activity

Learn More

Open the live DNA dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.